Want to see JP:4438 full AI Analyst Report?
4438 Stock Chart & Stats
¥279.00
¥1.00(0.29%)
At close: 4:00 PM EST
¥279.00
¥1.00(0.29%)
Day’s Range― - ―
52-Week Range¥231.00 - ¥558.00
Previous CloseN/A
Volume4.50K
Average Volume (3M)3.91K
Market Cap
¥2.00B
Enterprise Value¥2.73K
Total Cash (Recent Filing)¥516.23M
Total Debt (Recent Filing)¥539.39M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-63.35
Shares Outstanding8,435,582
10 Day Avg. Volume3,070
30 Day Avg. Volume3,910
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)8.48
Price to Sales (P/S)3.63
P/FCF Ratio-6.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained ~71% gross margins indicate strong unit economics and pricing power in its healthcare information services. Over a multi-month horizon this supports scalable revenue conversion to operating leverage if fixed costs are reined in, making the core business structurally profitable once SG&A trends improve.
Sharp 2025 Revenue ReboundA ~78% revenue rebound in 2025 signals renewed commercial traction and demand for the company’s offerings. Durable top-line recovery suggests product-market fit improvements and potential for continued growth, which can allow fixed costs to be absorbed and support a path toward sustainable profitability over several quarters.
Sizable Asset BaseHolding ~¥1.05bn in total assets provides a tangible operational cushion and potential collateral for financing. Over the medium term this asset base can be used to support service delivery, secure lending or strategic investments, improving the company’s ability to execute growth initiatives while seeking profitability.
Bears Say
Deep Persistent LossesVery large negative net margins (~-85%) reflect a structural failure to convert high gross profit into operating profitability. Persistent deep losses erode equity, limit reinvestment capacity and make long-term planning reliant on external funding, raising execution risk if revenue growth slows or costs remain elevated.
Consistent Negative Cash FlowNegative operating and free cash flow in 2025 show the business is burning cash to sustain operations. Continued cash burn reduces runway, forces dependence on external financing, constrains strategic choices and increases vulnerability to funding market conditions, posing a durable liquidity risk absent rapid cash-flow improvement.
Materially Increased LeverageDebt rising to ~¥606m and debt-to-equity ~2.22x marks a marked deterioration in financial flexibility versus prior years. Higher leverage increases fixed interest obligations and refinancing risk, limiting the company’s ability to invest in growth or absorb shocks and heightening solvency concerns if losses persist.
4438 FAQ
What was Welby Inc.’s price range in the past 12 months?
Welby Inc. lowest stock price was ¥231.00 and its highest was ¥558.00 in the past 12 months.
What is Welby Inc.’s market cap?
Welby Inc.’s market cap is ¥2.00B.
When is Welby Inc.’s upcoming earnings report date?
Welby Inc.’s upcoming earnings report date is Aug 13, 2026 which is in 23 days.
How were Welby Inc.’s earnings last quarter?
Welby Inc. released its earnings results on May 15, 2026. The company reported -¥18.41 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Welby Inc. overvalued?
According to Wall Street analysts Welby Inc.’s price is currently Overvalued.
Does Welby Inc. pay dividends?
Welby Inc. does not currently pay dividends.
What is Welby Inc.’s EPS estimate?
Welby Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Welby Inc. have?
Welby Inc. has 8,435,582 shares outstanding.
What happened to Welby Inc.’s price movement after its last earnings report?
Welby Inc. reported an EPS of -¥18.41 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.051%.
Which hedge fund is a major shareholder of Welby Inc.?
Currently, no hedge funds are holding shares in JP:4438
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Welby Inc.
Established in Tokyo, Japan, in 2011, Welby Inc. specializes in developing digital healthcare solutions aimed at enhancing patients' access to and engagement with medical services. The company's extensive portfolio addresses a wide array of health conditions, encompassing diabetes mellitus, lifestyle-related diseases, mental health disorders, autoimmune and neurological diseases, rare conditions, oncology, and pain management. Furthermore, Welby is active in medical data surveying and operates its signature platform, Welby My Carte.